Survival curves generated using a combination of two factors, i.e., NPC1L1 expression and stage revealed that the median value for CRC patients with the high stage/high NPC1L1 expression was 3.18 years, and that these patients showed a worse prognosis (Fig. 4b). Here, NPC1L1 is linked to colorectal carcinoma.